id,indicator_code,spatial_dim_type,iso_code,region_code,time_dim_type,region,dim1type,year,dim1,dim2type,dim2,dim3type,dim3,data_source_dim_type,data_source_dim,value,numeric_value,low,high,comments,date,time_dimension_value,time_dimension_begin,time_dimension_end,country,indicator_name,language,title
1214143,GASPRSCFM,COUNTRY,GRC,EUR,YEAR,Europe,NA,2014,NA,NA,NA,NA,NA,NA,NA,2.73,2.72727,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Greece,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5544369,GASPRSCFM,COUNTRY,BEL,EUR,YEAR,Europe,NA,2010,NA,NA,NA,NA,NA,NA,NA,3.64,3.63636,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Belgium,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5955955,GASPRSCFM,COUNTRY,UKR,EUR,YEAR,Europe,NA,2018,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Ukraine,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3084396,GASPRSCFM,COUNTRY,SWE,EUR,YEAR,Europe,NA,2009,NA,NA,NA,NA,NA,NA,NA,2.78,2.77778,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Sweden,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
510121,GASPRSCFM,COUNTRY,ESP,EUR,YEAR,Europe,NA,2015,NA,NA,NA,NA,NA,NA,NA,2.4,2.39521,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Spain,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9307483,GASPRSCFM,COUNTRY,UGA,AFR,YEAR,Africa,NA,2018,NA,NA,NA,NA,NA,NA,NA,0,0.003,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Uganda,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
364262,GASPRSCFM,COUNTRY,NLD,EUR,YEAR,Europe,NA,2010,NA,NA,NA,NA,NA,NA,NA,3.26,3.25581,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9998117,GASPRSCFM,COUNTRY,BLR,EUR,YEAR,Europe,NA,2017,NA,NA,NA,NA,NA,NA,NA,22.2,22.2,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Belarus,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5228109,GASPRSCFM,COUNTRY,CUB,AMR,YEAR,Americas,NA,2017,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Cuba,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2825506,GASPRSCFM,COUNTRY,USA,AMR,YEAR,Americas,NA,2009,NA,NA,NA,NA,NA,NA,NA,0.8,0.79929,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,United States of America,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7796824,GASPRSCFM,COUNTRY,CHL,AMR,YEAR,Americas,NA,2018,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Chile,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9491447,GASPRSCFM,COUNTRY,CAN,AMR,YEAR,Americas,NA,2010,NA,NA,NA,NA,NA,NA,NA,3.3,3.29966,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Canada,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1467648,GASPRSCFM,COUNTRY,AUT,EUR,YEAR,Europe,NA,2011,NA,NA,NA,NA,NA,NA,NA,13.21,13.20755,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Austria,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4026629,GASPRSCFM,COUNTRY,GBR,EUR,YEAR,Europe,NA,2017,NA,NA,NA,NA,NA,NA,NA,1.3,1.3,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4659475,GASPRSCFM,COUNTRY,ZAF,AFR,YEAR,Africa,NA,2016,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,South Africa,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9187372,GASPRSCFM,COUNTRY,PRT,EUR,YEAR,Europe,NA,2011,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Portugal,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6842509,GASPRSCFM,COUNTRY,DOM,AMR,YEAR,Americas,NA,2018,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Dominican Republic,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1347538,GASPRSCFM,COUNTRY,BRA,AMR,YEAR,Americas,NA,2016,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Brazil,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3578148,GASPRSCFM,COUNTRY,GBR,EUR,YEAR,Europe,NA,2018,NA,NA,NA,NA,NA,NA,NA,1.2,1.2,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5500666,GASPRSCFM,COUNTRY,AUT,EUR,YEAR,Europe,NA,2010,NA,NA,NA,NA,NA,NA,NA,22.73,22.72727,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Austria,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2441055,GASPRSCFM,COUNTRY,GRC,EUR,YEAR,Europe,NA,2010,NA,NA,NA,NA,NA,NA,NA,13.4,13.40206,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Greece,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8800373,GASPRSCFM,COUNTRY,PER,AMR,YEAR,Americas,NA,2018,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Peru,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7784474,GASPRSCFM,COUNTRY,SVK,EUR,YEAR,Europe,NA,2010,NA,NA,NA,NA,NA,NA,NA,14.77,14.77273,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Slovakia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1214673,GASPRSCFM,COUNTRY,USA,AMR,YEAR,Americas,NA,2014,NA,NA,NA,NA,NA,NA,NA,0.75,0.74612,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,United States of America,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9536102,GASPRSCFM,COUNTRY,NLD,EUR,YEAR,Europe,NA,2012,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6222127,GASPRSCFM,COUNTRY,POL,EUR,YEAR,Europe,NA,2018,NA,NA,NA,NA,NA,NA,NA,1.4,1.4,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Poland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9035177,GASPRSCFM,COUNTRY,ARG,AMR,YEAR,Americas,NA,2018,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Argentina,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3464285,GASPRSCFM,COUNTRY,ROU,EUR,YEAR,Europe,NA,2010,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Romania,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9681956,GASPRSCFM,COUNTRY,POL,EUR,YEAR,Europe,NA,2010,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Poland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5361070,GASPRSCFM,COUNTRY,EST,EUR,YEAR,Europe,NA,2015,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Estonia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4045963,GASPRSCFM,COUNTRY,PRT,EUR,YEAR,Europe,NA,2017,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Portugal,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3786482,GASPRSCFM,COUNTRY,NLD,EUR,YEAR,Europe,NA,2017,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4438048,GASPRSCFM,COUNTRY,LKA,SEAR,YEAR,South-East Asia,NA,2016,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Sri Lanka,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2940224,GASPRSCFM,COUNTRY,SVN,EUR,YEAR,Europe,NA,2017,NA,NA,NA,NA,NA,NA,NA,1.5,1.5,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Slovenia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7178064,GASPRSCFM,COUNTRY,PAN,AMR,YEAR,Americas,NA,2018,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Panama,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8357600,GASPRSCFM,COUNTRY,PRT,EUR,YEAR,Europe,NA,2012,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Portugal,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6691039,GASPRSCFM,COUNTRY,NLD,EUR,YEAR,Europe,NA,2016,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3951071,GASPRSCFM,COUNTRY,DEU,EUR,YEAR,Europe,NA,2009,NA,NA,NA,NA,NA,NA,NA,2.22,2.22222,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Germany,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5703862,GASPRSCFM,COUNTRY,CIV,AFR,YEAR,Africa,NA,2018,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Cote d'Ivoire,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8471502,GASPRSCFM,COUNTRY,AUT,EUR,YEAR,Europe,NA,2009,NA,NA,NA,NA,NA,NA,NA,21.15,21.15385,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Austria,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7829250,GASPRSCFM,COUNTRY,THA,SEAR,YEAR,South-East Asia,NA,2015,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Thailand,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7860527,GASPRSCFM,COUNTRY,SWE,EUR,YEAR,Europe,NA,2017,NA,NA,NA,NA,NA,NA,NA,2,2,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Sweden,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6653236,GASPRSCFM,COUNTRY,USA,AMR,YEAR,Americas,NA,2016,NA,NA,NA,NA,NA,NA,NA,0.32,0.32344,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,United States of America,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
10017707,GASPRSCFM,COUNTRY,PRY,AMR,YEAR,Americas,NA,2016,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Paraguay,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
175189,GASPRSCFM,COUNTRY,ESP,EUR,YEAR,Europe,NA,2013,NA,NA,NA,NA,NA,NA,NA,15.13,15.12605,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Spain,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6779689,GASPRSCFM,COUNTRY,DEU,EUR,YEAR,Europe,NA,2011,NA,NA,NA,NA,NA,NA,NA,10.19,10.18519,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Germany,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4755015,GASPRSCFM,COUNTRY,HUN,EUR,YEAR,Europe,NA,2017,NA,NA,NA,NA,NA,NA,NA,6.5,6.5,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Hungary,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8287962,GASPRSCFM,COUNTRY,PER,AMR,YEAR,Americas,NA,2017,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Peru,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5114697,GASPRSCFM,COUNTRY,SVK,EUR,YEAR,Europe,NA,2017,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Slovakia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1259634,GASPRSCFM,COUNTRY,ESP,EUR,YEAR,Europe,NA,2018,NA,NA,NA,NA,NA,NA,NA,4.8,4.8,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Spain,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9973659,GASPRSCFM,COUNTRY,CYP,EUR,YEAR,Europe,NA,2015,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Cyprus,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3464711,GASPRSCFM,COUNTRY,DNK,EUR,YEAR,Europe,NA,2016,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Denmark,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3869075,GASPRSCFM,COUNTRY,POL,EUR,YEAR,Europe,NA,2017,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Poland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4128796,GASPRSCFM,COUNTRY,SVN,EUR,YEAR,Europe,NA,2012,NA,NA,NA,NA,NA,NA,NA,4.26,4.25532,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Slovenia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7886226,GASPRSCFM,COUNTRY,GBR,EUR,YEAR,Europe,NA,2016,NA,NA,NA,NA,NA,NA,NA,0.86,0.85837,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4615616,GASPRSCFM,COUNTRY,DEU,EUR,YEAR,Europe,NA,2010,NA,NA,NA,NA,NA,NA,NA,11.93,11.92661,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Germany,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7064330,GASPRSCFM,COUNTRY,POL,EUR,YEAR,Europe,NA,2011,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Poland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2543294,GASPRSCFM,COUNTRY,SVK,EUR,YEAR,Europe,NA,2015,NA,NA,NA,NA,NA,NA,NA,3.85,3.84615,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Slovakia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7926344,GASPRSCFM,COUNTRY,ZAF,AFR,YEAR,Africa,NA,2013,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,South Africa,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2594095,GASPRSCFM,COUNTRY,SWE,EUR,YEAR,Europe,NA,2011,NA,NA,NA,NA,NA,NA,NA,7.62,7.61905,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Sweden,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8687133,GASPRSCFM,COUNTRY,URY,AMR,YEAR,Americas,NA,2018,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Uruguay,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7598145,GASPRSCFM,COUNTRY,SVK,EUR,YEAR,Europe,NA,2016,NA,NA,NA,NA,NA,NA,NA,3.64,3.63636,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Slovakia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8224711,GASPRSCFM,COUNTRY,HRV,EUR,YEAR,Europe,NA,2016,NA,NA,NA,NA,NA,NA,NA,11.11,11.11111,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Croatia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
720739,GASPRSCFM,COUNTRY,AUT,EUR,YEAR,Europe,NA,2018,NA,NA,NA,NA,NA,NA,NA,3.4,3.4,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Austria,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8756566,GASPRSCFM,COUNTRY,GBR,EUR,YEAR,Europe,NA,2015,NA,NA,NA,NA,NA,NA,NA,0.42,0.41841,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8877104,GASPRSCFM,COUNTRY,DEU,EUR,YEAR,Europe,NA,2012,NA,NA,NA,NA,NA,NA,NA,5.66,5.66038,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Germany,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6399720,GASPRSCFM,COUNTRY,KEN,AFR,YEAR,Africa,NA,2018,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Kenya,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
492279,GASPRSCFM,COUNTRY,NLD,EUR,YEAR,Europe,NA,2013,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8377018,GASPRSCFM,COUNTRY,ROU,EUR,YEAR,Europe,NA,2011,NA,NA,NA,NA,NA,NA,NA,15.38,15.38462,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Romania,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7315343,GASPRSCFM,COUNTRY,PRT,EUR,YEAR,Europe,NA,2014,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Portugal,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2587985,GASPRSCFM,COUNTRY,GBR,EUR,YEAR,Europe,NA,2009,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1063047,GASPRSCFM,COUNTRY,PRY,AMR,YEAR,Americas,NA,2018,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Paraguay,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4375543,GASPRSCFM,COUNTRY,FRA,EUR,YEAR,Europe,NA,2014,NA,NA,NA,NA,NA,NA,NA,0.91,0.90909,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,France,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5051855,GASPRSCFM,COUNTRY,ISL,EUR,YEAR,Europe,NA,2013,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Iceland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3989793,GASPRSCFM,COUNTRY,NOR,EUR,YEAR,Europe,NA,2014,NA,NA,NA,NA,NA,NA,NA,5.45,5.45455,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Norway,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8370953,GASPRSCFM,COUNTRY,COL,AMR,YEAR,Americas,NA,2018,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Colombia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2302090,GASPRSCFM,COUNTRY,ARE,EMR,YEAR,Eastern Mediterranean,NA,2017,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,United Arab Emirates,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2782959,GASPRSCFM,COUNTRY,KEN,AFR,YEAR,Africa,NA,2014,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Kenya,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7759967,GASPRSCFM,COUNTRY,CYP,EUR,YEAR,Europe,NA,2017,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Cyprus,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5957218,GASPRSCFM,COUNTRY,ITA,EUR,YEAR,Europe,NA,2010,NA,NA,NA,NA,NA,NA,NA,5.71,5.71429,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Italy,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4230169,GASPRSCFM,COUNTRY,ITA,EUR,YEAR,Europe,NA,2017,NA,NA,NA,NA,NA,NA,NA,2,2,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Italy,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8649411,GASPRSCFM,COUNTRY,BEL,EUR,YEAR,Europe,NA,2017,NA,NA,NA,NA,NA,NA,NA,2,2,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Belgium,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6501610,GASPRSCFM,COUNTRY,HUN,EUR,YEAR,Europe,NA,2013,NA,NA,NA,NA,NA,NA,NA,6.82,6.81818,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Hungary,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
10145177,GASPRSCFM,COUNTRY,USA,AMR,YEAR,Americas,NA,2010,NA,NA,NA,NA,NA,NA,NA,0.14,0.14052,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,United States of America,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8504131,GASPRSCFM,COUNTRY,CYP,EUR,YEAR,Europe,NA,2018,NA,NA,NA,NA,NA,NA,NA,20,20,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Cyprus,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6216870,GASPRSCFM,COUNTRY,ESP,EUR,YEAR,Europe,NA,2011,NA,NA,NA,NA,NA,NA,NA,15,15,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Spain,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6425517,GASPRSCFM,COUNTRY,BTN,SEAR,YEAR,South-East Asia,NA,2015,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Bhutan,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2808183,GASPRSCFM,COUNTRY,EST,EUR,YEAR,Europe,NA,2018,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Estonia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2833365,GASPRSCFM,COUNTRY,AUT,EUR,YEAR,Europe,NA,2012,NA,NA,NA,NA,NA,NA,NA,4.67,4.6729,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Austria,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2947562,GASPRSCFM,COUNTRY,CIV,AFR,YEAR,Africa,NA,2015,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Cote d'Ivoire,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6679472,GASPRSCFM,COUNTRY,SWE,EUR,YEAR,Europe,NA,2018,NA,NA,NA,NA,NA,NA,NA,1.5,1.5,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Sweden,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5495609,GASPRSCFM,COUNTRY,FIN,EUR,YEAR,Europe,NA,2018,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Finland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5071366,GASPRSCFM,COUNTRY,POL,EUR,YEAR,Europe,NA,2012,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Poland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
930438,GASPRSCFM,COUNTRY,CHE,EUR,YEAR,Europe,NA,2018,NA,NA,NA,NA,NA,NA,NA,5.56,5.55556,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Switzerland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2308883,GASPRSCFM,COUNTRY,FRA,EUR,YEAR,Europe,NA,2015,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,France,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
30968,GASPRSCFM,COUNTRY,LVA,EUR,YEAR,Europe,NA,2018,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Latvia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
176160,GASPRSCFM,COUNTRY,HUN,EUR,YEAR,Europe,NA,2010,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Hungary,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2663646,GASPRSCFM,COUNTRY,CYP,EUR,YEAR,Europe,NA,2010,NA,NA,NA,NA,NA,NA,NA,50,50,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Cyprus,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5153752,GASPRSCFM,COUNTRY,ESP,EUR,YEAR,Europe,NA,2012,NA,NA,NA,NA,NA,NA,NA,15.24,15.2381,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Spain,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4648360,GASPRSCFM,COUNTRY,HUN,EUR,YEAR,Europe,NA,2016,NA,NA,NA,NA,NA,NA,NA,8.51,8.51064,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Hungary,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9112936,GASPRSCFM,COUNTRY,NOR,EUR,YEAR,Europe,NA,2009,NA,NA,NA,NA,NA,NA,NA,0.91,0.90909,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Norway,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7554417,GASPRSCFM,COUNTRY,ESP,EUR,YEAR,Europe,NA,2009,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Spain,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2701437,GASPRSCFM,COUNTRY,ITA,EUR,YEAR,Europe,NA,2009,NA,NA,NA,NA,NA,NA,NA,18.57,18.57143,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Italy,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4540349,GASPRSCFM,COUNTRY,BLR,EUR,YEAR,Europe,NA,2010,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Belarus,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9138399,GASPRSCFM,COUNTRY,LVA,EUR,YEAR,Europe,NA,2015,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Latvia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9879744,GASPRSCFM,COUNTRY,NOR,EUR,YEAR,Europe,NA,2013,NA,NA,NA,NA,NA,NA,NA,4.46,4.46429,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Norway,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4857089,GASPRSCFM,COUNTRY,GRC,EUR,YEAR,Europe,NA,2009,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Greece,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5362503,GASPRSCFM,COUNTRY,FRA,EUR,YEAR,Europe,NA,2018,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,France,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8200357,GASPRSCFM,COUNTRY,LUX,EUR,YEAR,Europe,NA,2016,NA,NA,NA,NA,NA,NA,NA,10,10,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Luxembourg,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6913456,GASPRSCFM,COUNTRY,GBR,EUR,YEAR,Europe,NA,2012,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6932566,GASPRSCFM,COUNTRY,THA,SEAR,YEAR,South-East Asia,NA,2016,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Thailand,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6166591,GASPRSCFM,COUNTRY,POL,EUR,YEAR,Europe,NA,2014,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Poland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1191005,GASPRSCFM,COUNTRY,IND,SEAR,YEAR,South-East Asia,NA,2016,NA,NA,NA,NA,NA,NA,NA,6.33,6.32911,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,India,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5204949,GASPRSCFM,COUNTRY,IRL,EUR,YEAR,Europe,NA,2013,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Ireland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
410798,GASPRSCFM,COUNTRY,SAU,EMR,YEAR,Eastern Mediterranean,NA,2017,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Saudi Arabia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4433325,GASPRSCFM,COUNTRY,DNK,EUR,YEAR,Europe,NA,2012,NA,NA,NA,NA,NA,NA,NA,12.28,12.2807,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Denmark,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2563563,GASPRSCFM,COUNTRY,BLR,EUR,YEAR,Europe,NA,2012,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Belarus,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5059179,GASPRSCFM,COUNTRY,CZE,EUR,YEAR,Europe,NA,2017,NA,NA,NA,NA,NA,NA,NA,1.9,1.9,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Czechia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1633643,GASPRSCFM,COUNTRY,ISL,EUR,YEAR,Europe,NA,2017,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Iceland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4262772,GASPRSCFM,COUNTRY,DEU,EUR,YEAR,Europe,NA,2013,NA,NA,NA,NA,NA,NA,NA,12.87,12.87129,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Germany,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3219949,GASPRSCFM,COUNTRY,SWE,EUR,YEAR,Europe,NA,2016,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Sweden,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5084675,GASPRSCFM,COUNTRY,MLT,EUR,YEAR,Europe,NA,2009,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Malta,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8232349,GASPRSCFM,COUNTRY,USA,AMR,YEAR,Americas,NA,2018,NA,NA,NA,NA,NA,NA,NA,0.29,0.2907,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,United States of America,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8789699,GASPRSCFM,COUNTRY,PRT,EUR,YEAR,Europe,NA,2010,NA,NA,NA,NA,NA,NA,NA,1.39,1.38889,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Portugal,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5255882,GASPRSCFM,COUNTRY,PRT,EUR,YEAR,Europe,NA,2009,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Portugal,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7110078,GASPRSCFM,COUNTRY,CHE,EUR,YEAR,Europe,NA,2017,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Switzerland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7643761,GASPRSCFM,COUNTRY,RUS,EUR,YEAR,Europe,NA,2011,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Russian Federation,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3296084,GASPRSCFM,COUNTRY,NLD,EUR,YEAR,Europe,NA,2015,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3327478,GASPRSCFM,COUNTRY,NOR,EUR,YEAR,Europe,NA,2017,NA,NA,NA,NA,NA,NA,NA,0.9,0.9,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Norway,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3586658,GASPRSCFM,COUNTRY,CYP,EUR,YEAR,Europe,NA,2014,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Cyprus,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9620522,GASPRSCFM,COUNTRY,AUT,EUR,YEAR,Europe,NA,2015,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Austria,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8251641,GASPRSCFM,COUNTRY,UKR,EUR,YEAR,Europe,NA,2017,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Ukraine,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8251656,GASPRSCFM,COUNTRY,SVN,EUR,YEAR,Europe,NA,2013,NA,NA,NA,NA,NA,NA,NA,1.37,1.36986,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Slovenia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1045451,GASPRSCFM,COUNTRY,MWI,AFR,YEAR,Africa,NA,2016,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Malawi,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7599699,GASPRSCFM,COUNTRY,IRL,EUR,YEAR,Europe,NA,2010,NA,NA,NA,NA,NA,NA,NA,4.55,4.54545,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Ireland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1539215,GASPRSCFM,COUNTRY,MLT,EUR,YEAR,Europe,NA,2016,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Malta,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6718387,GASPRSCFM,COUNTRY,SWE,EUR,YEAR,Europe,NA,2010,NA,NA,NA,NA,NA,NA,NA,7.14,7.14286,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Sweden,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7180089,GASPRSCFM,COUNTRY,KEN,AFR,YEAR,Africa,NA,2010,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Kenya,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4383255,GASPRSCFM,COUNTRY,SWE,EUR,YEAR,Europe,NA,2012,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Sweden,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6585148,GASPRSCFM,COUNTRY,ZAF,AFR,YEAR,Africa,NA,2018,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,South Africa,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3377959,GASPRSCFM,COUNTRY,AUT,EUR,YEAR,Europe,NA,2014,NA,NA,NA,NA,NA,NA,NA,0.99,0.9901,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Austria,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3251849,GASPRSCFM,COUNTRY,CYP,EUR,YEAR,Europe,NA,2012,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Cyprus,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4889528,GASPRSCFM,COUNTRY,PRT,EUR,YEAR,Europe,NA,2016,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Portugal,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4706257,GASPRSCFM,COUNTRY,CAN,AMR,YEAR,Americas,NA,2018,NA,NA,NA,NA,NA,NA,NA,0.54,0.54452,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Canada,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6984004,GASPRSCFM,COUNTRY,HUN,EUR,YEAR,Europe,NA,2011,NA,NA,NA,NA,NA,NA,NA,7.69,7.69231,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Hungary,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4965043,GASPRSCFM,COUNTRY,SVN,EUR,YEAR,Europe,NA,2016,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Slovenia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7953522,GASPRSCFM,COUNTRY,CAN,AMR,YEAR,Americas,NA,2009,NA,NA,NA,NA,NA,NA,NA,1.13,1.12685,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Canada,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6926843,GASPRSCFM,COUNTRY,BEL,EUR,YEAR,Europe,NA,2015,NA,NA,NA,NA,NA,NA,NA,11.11,11.11111,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Belgium,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2923526,GASPRSCFM,COUNTRY,POL,EUR,YEAR,Europe,NA,2016,NA,NA,NA,NA,NA,NA,NA,5.19,5.19481,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Poland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
595585,GASPRSCFM,COUNTRY,BEL,EUR,YEAR,Europe,NA,2011,NA,NA,NA,NA,NA,NA,NA,0.91,0.90909,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Belgium,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6629912,GASPRSCFM,COUNTRY,SVN,EUR,YEAR,Europe,NA,2018,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Slovenia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7536400,GASPRSCFM,COUNTRY,NOR,EUR,YEAR,Europe,NA,2018,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Norway,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3042958,GASPRSCFM,COUNTRY,ARG,AMR,YEAR,Americas,NA,2016,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Argentina,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9918771,GASPRSCFM,COUNTRY,ISR,EUR,YEAR,Europe,NA,2011,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Israel,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6636359,GASPRSCFM,COUNTRY,PHL,WPR,YEAR,Western Pacific,NA,2018,NA,NA,NA,NA,NA,NA,NA,4.21,4.21053,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Philippines,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4908766,GASPRSCFM,COUNTRY,GBR,EUR,YEAR,Europe,NA,2014,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8182171,GASPRSCFM,COUNTRY,MLT,EUR,YEAR,Europe,NA,2011,NA,NA,NA,NA,NA,NA,NA,7.69,7.69231,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Malta,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
741347,GASPRSCFM,COUNTRY,MLT,EUR,YEAR,Europe,NA,2010,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Malta,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6756397,GASPRSCFM,COUNTRY,GRC,EUR,YEAR,Europe,NA,2013,NA,NA,NA,NA,NA,NA,NA,14.67,14.66667,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Greece,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
417993,GASPRSCFM,COUNTRY,LUX,EUR,YEAR,Europe,NA,2018,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Luxembourg,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5344692,GASPRSCFM,COUNTRY,CZE,EUR,YEAR,Europe,NA,2016,NA,NA,NA,NA,NA,NA,NA,1.11,1.11111,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Czechia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5839339,GASPRSCFM,COUNTRY,ISL,EUR,YEAR,Europe,NA,2018,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Iceland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8429517,GASPRSCFM,COUNTRY,EST,EUR,YEAR,Europe,NA,2014,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Estonia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5990685,GASPRSCFM,COUNTRY,LUX,EUR,YEAR,Europe,NA,2017,NA,NA,NA,NA,NA,NA,NA,5.6,5.6,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Luxembourg,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
10134078,GASPRSCFM,COUNTRY,ITA,EUR,YEAR,Europe,NA,2014,NA,NA,NA,NA,NA,NA,NA,2,2,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Italy,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1722540,GASPRSCFM,COUNTRY,GBR,EUR,YEAR,Europe,NA,2010,NA,NA,NA,NA,NA,NA,NA,3.15,3.15315,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7148832,GASPRSCFM,COUNTRY,ECU,AMR,YEAR,Americas,NA,2017,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Ecuador,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7244148,GASPRSCFM,COUNTRY,NLD,EUR,YEAR,Europe,NA,2009,NA,NA,NA,NA,NA,NA,NA,0.88,0.87719,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9703826,GASPRSCFM,COUNTRY,DNK,EUR,YEAR,Europe,NA,2013,NA,NA,NA,NA,NA,NA,NA,11.82,11.81818,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Denmark,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7187049,GASPRSCFM,COUNTRY,CAN,AMR,YEAR,Americas,NA,2017,NA,NA,NA,NA,NA,NA,NA,0.68,0.6812,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Canada,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4503845,GASPRSCFM,COUNTRY,BEL,EUR,YEAR,Europe,NA,2016,NA,NA,NA,NA,NA,NA,NA,8.08,8.08081,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Belgium,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2228503,GASPRSCFM,COUNTRY,EST,EUR,YEAR,Europe,NA,2016,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Estonia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6883412,GASPRSCFM,COUNTRY,DEU,EUR,YEAR,Europe,NA,2016,NA,NA,NA,NA,NA,NA,NA,6.42,6.42202,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Germany,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5630315,GASPRSCFM,COUNTRY,FRA,EUR,YEAR,Europe,NA,2013,NA,NA,NA,NA,NA,NA,NA,3.57,3.57143,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,France,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4340035,GASPRSCFM,COUNTRY,ARE,EMR,YEAR,Eastern Mediterranean,NA,2018,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,United Arab Emirates,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8220728,GASPRSCFM,COUNTRY,HUN,EUR,YEAR,Europe,NA,2014,NA,NA,NA,NA,NA,NA,NA,1.12,1.1236,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Hungary,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9925673,GASPRSCFM,COUNTRY,COL,AMR,YEAR,Americas,NA,2017,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Colombia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8771711,GASPRSCFM,COUNTRY,IDN,WPR,YEAR,Western Pacific,NA,2015,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Indonesia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
291485,GASPRSCFM,COUNTRY,MLT,EUR,YEAR,Europe,NA,2018,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Malta,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2127693,GASPRSCFM,COUNTRY,LVA,EUR,YEAR,Europe,NA,2009,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Latvia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7288443,GASPRSCFM,COUNTRY,MMR,SEAR,YEAR,South-East Asia,NA,2016,NA,NA,NA,NA,NA,NA,NA,66.67,66.66667,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Myanmar,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1722919,GASPRSCFM,COUNTRY,MUS,AFR,YEAR,Africa,NA,2012,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Mauritius,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7269645,GASPRSCFM,COUNTRY,GRC,EUR,YEAR,Europe,NA,2015,NA,NA,NA,NA,NA,NA,NA,11,11,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Greece,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1420623,GASPRSCFM,COUNTRY,NOR,EUR,YEAR,Europe,NA,2015,NA,NA,NA,NA,NA,NA,NA,0.91,0.90909,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Norway,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9133700,GASPRSCFM,COUNTRY,IRL,EUR,YEAR,Europe,NA,2014,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Ireland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5098576,GASPRSCFM,COUNTRY,BLR,EUR,YEAR,Europe,NA,2018,NA,NA,NA,NA,NA,NA,NA,15.8,15.8,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Belarus,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3613076,GASPRSCFM,COUNTRY,USA,AMR,YEAR,Americas,NA,2012,NA,NA,NA,NA,NA,NA,NA,0.09,0.09099,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,United States of America,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
767408,GASPRSCFM,COUNTRY,ITA,EUR,YEAR,Europe,NA,2011,NA,NA,NA,NA,NA,NA,NA,3.03,3.0303,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Italy,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
10045932,GASPRSCFM,COUNTRY,SVK,EUR,YEAR,Europe,NA,2009,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Slovakia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7437914,GASPRSCFM,COUNTRY,FRA,EUR,YEAR,Europe,NA,2010,NA,NA,NA,NA,NA,NA,NA,1.8,1.8018,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,France,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2298080,GASPRSCFM,COUNTRY,AUT,EUR,YEAR,Europe,NA,2016,NA,NA,NA,NA,NA,NA,NA,4.17,4.16667,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Austria,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
729465,GASPRSCFM,COUNTRY,NLD,EUR,YEAR,Europe,NA,2011,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
405953,GASPRSCFM,COUNTRY,SVN,EUR,YEAR,Europe,NA,2014,NA,NA,NA,NA,NA,NA,NA,1.22,1.21951,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Slovenia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5909196,GASPRSCFM,COUNTRY,UGA,AFR,YEAR,Africa,NA,2017,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Uganda,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
507600,GASPRSCFM,COUNTRY,CAN,AMR,YEAR,Americas,NA,2012,NA,NA,NA,NA,NA,NA,NA,2.24,2.23979,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Canada,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2728715,GASPRSCFM,COUNTRY,USA,AMR,YEAR,Americas,NA,2013,NA,NA,NA,NA,NA,NA,NA,0.4,0.4037,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,United States of America,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9127551,GASPRSCFM,COUNTRY,ISL,EUR,YEAR,Europe,NA,2016,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Iceland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9450786,GASPRSCFM,COUNTRY,UGA,AFR,YEAR,Africa,NA,2011,NA,NA,NA,NA,NA,NA,NA,0.66,0.66225,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Uganda,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4118988,GASPRSCFM,COUNTRY,CAN,AMR,YEAR,Americas,NA,2011,NA,NA,NA,NA,NA,NA,NA,4.17,4.16667,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Canada,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1768245,GASPRSCFM,COUNTRY,HRV,EUR,YEAR,Europe,NA,2018,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Croatia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
10103161,GASPRSCFM,COUNTRY,GBR,EUR,YEAR,Europe,NA,2011,NA,NA,NA,NA,NA,NA,NA,2.79,2.78884,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3568944,GASPRSCFM,COUNTRY,MLT,EUR,YEAR,Europe,NA,2012,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Malta,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6927946,GASPRSCFM,COUNTRY,IND,SEAR,YEAR,South-East Asia,NA,2015,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,India,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6478692,GASPRSCFM,COUNTRY,HUN,EUR,YEAR,Europe,NA,2015,NA,NA,NA,NA,NA,NA,NA,1.56,1.5625,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Hungary,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4599528,GASPRSCFM,COUNTRY,ITA,EUR,YEAR,Europe,NA,2015,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Italy,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3664062,GASPRSCFM,COUNTRY,DOM,AMR,YEAR,Americas,NA,2017,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Dominican Republic,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6713404,GASPRSCFM,COUNTRY,CZE,EUR,YEAR,Europe,NA,2018,NA,NA,NA,NA,NA,NA,NA,1.1,1.1,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Czechia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
558683,GASPRSCFM,COUNTRY,PRT,EUR,YEAR,Europe,NA,2015,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Portugal,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
10224032,GASPRSCFM,COUNTRY,CHL,AMR,YEAR,Americas,NA,2016,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Chile,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2235591,GASPRSCFM,COUNTRY,HRV,EUR,YEAR,Europe,NA,2015,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Croatia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
806089,GASPRSCFM,COUNTRY,SVK,EUR,YEAR,Europe,NA,2011,NA,NA,NA,NA,NA,NA,NA,36.28,36.28319,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Slovakia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7813556,GASPRSCFM,COUNTRY,ARG,AMR,YEAR,Americas,NA,2015,NA,NA,NA,NA,NA,NA,NA,0.14,0.13736,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Argentina,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
10166950,GASPRSCFM,COUNTRY,DNK,EUR,YEAR,Europe,NA,2015,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Denmark,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6390076,GASPRSCFM,COUNTRY,FRA,EUR,YEAR,Europe,NA,2012,NA,NA,NA,NA,NA,NA,NA,1.82,1.81818,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,France,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6618487,GASPRSCFM,COUNTRY,SVN,EUR,YEAR,Europe,NA,2011,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Slovenia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
546105,GASPRSCFM,COUNTRY,ZWE,AFR,YEAR,Africa,NA,2010,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Zimbabwe,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4783341,GASPRSCFM,COUNTRY,ESP,EUR,YEAR,Europe,NA,2010,NA,NA,NA,NA,NA,NA,NA,15.84,15.84158,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Spain,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7024897,GASPRSCFM,COUNTRY,POL,EUR,YEAR,Europe,NA,2015,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Poland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7031417,GASPRSCFM,COUNTRY,IRL,EUR,YEAR,Europe,NA,2015,NA,NA,NA,NA,NA,NA,NA,0.91,0.90909,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Ireland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7124754,GASPRSCFM,COUNTRY,USA,AMR,YEAR,Americas,NA,2017,NA,NA,NA,NA,NA,NA,NA,0.43,0.4347,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,United States of America,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7234053,GASPRSCFM,COUNTRY,IRL,EUR,YEAR,Europe,NA,2016,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Ireland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7240809,GASPRSCFM,COUNTRY,NOR,EUR,YEAR,Europe,NA,2010,NA,NA,NA,NA,NA,NA,NA,6.52,6.52174,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Norway,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7276963,GASPRSCFM,COUNTRY,DEU,EUR,YEAR,Europe,NA,2018,NA,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Germany,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7306870,GASPRSCFM,COUNTRY,BEL,EUR,YEAR,Europe,NA,2013,NA,NA,NA,NA,NA,NA,NA,6.36,6.36364,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Belgium,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7370508,GASPRSCFM,COUNTRY,KGZ,EUR,YEAR,Europe,NA,2016,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Kyrgyzstan,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7413352,GASPRSCFM,COUNTRY,SWE,EUR,YEAR,Europe,NA,2015,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Sweden,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7538783,GASPRSCFM,COUNTRY,USA,AMR,YEAR,Americas,NA,2011,NA,NA,NA,NA,NA,NA,NA,0.13,0.12804,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,United States of America,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7620760,GASPRSCFM,COUNTRY,ESP,EUR,YEAR,Europe,NA,2017,NA,NA,NA,NA,NA,NA,NA,5.5,5.5,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Spain,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7866067,GASPRSCFM,COUNTRY,GRC,EUR,YEAR,Europe,NA,2016,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Greece,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7883466,GASPRSCFM,COUNTRY,DEU,EUR,YEAR,Europe,NA,2015,NA,NA,NA,NA,NA,NA,NA,1.83,1.83486,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Germany,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
40367,GASPRSCFM,COUNTRY,DNK,EUR,YEAR,Europe,NA,2009,NA,NA,NA,NA,NA,NA,NA,15.13,15.12605,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Denmark,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
89869,GASPRSCFM,COUNTRY,LVA,EUR,YEAR,Europe,NA,2012,NA,NA,NA,NA,NA,NA,NA,2.56,2.5641,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Latvia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
104470,GASPRSCFM,COUNTRY,BEL,EUR,YEAR,Europe,NA,2009,NA,NA,NA,NA,NA,NA,NA,6.36,6.36364,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Belgium,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
186606,GASPRSCFM,COUNTRY,MLT,EUR,YEAR,Europe,NA,2017,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Malta,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
387724,GASPRSCFM,COUNTRY,SVN,EUR,YEAR,Europe,NA,2010,NA,NA,NA,NA,NA,NA,NA,25,25,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Slovenia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
521619,GASPRSCFM,COUNTRY,PRY,AMR,YEAR,Americas,NA,2015,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Paraguay,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
850484,GASPRSCFM,COUNTRY,LVA,EUR,YEAR,Europe,NA,2014,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Latvia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
850567,GASPRSCFM,COUNTRY,EST,EUR,YEAR,Europe,NA,2017,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Estonia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1021877,GASPRSCFM,COUNTRY,NLD,EUR,YEAR,Europe,NA,2018,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1123392,GASPRSCFM,COUNTRY,FRA,EUR,YEAR,Europe,NA,2009,NA,NA,NA,NA,NA,NA,NA,1.92,1.92308,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,France,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1257372,GASPRSCFM,COUNTRY,SAU,EMR,YEAR,Eastern Mediterranean,NA,2018,NA,NA,NA,NA,NA,NA,NA,16.67,16.66667,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Saudi Arabia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1269729,GASPRSCFM,COUNTRY,PAK,EMR,YEAR,Eastern Mediterranean,NA,2016,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Pakistan,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1440485,GASPRSCFM,COUNTRY,NOR,EUR,YEAR,Europe,NA,2012,NA,NA,NA,NA,NA,NA,NA,5.45,5.45455,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Norway,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1692337,GASPRSCFM,COUNTRY,RUS,EUR,YEAR,Europe,NA,2016,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Russian Federation,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1857102,GASPRSCFM,COUNTRY,ITA,EUR,YEAR,Europe,NA,2018,NA,NA,NA,NA,NA,NA,NA,5,5,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Italy,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1862423,GASPRSCFM,COUNTRY,DNK,EUR,YEAR,Europe,NA,2017,NA,NA,NA,NA,NA,NA,NA,0.8,0.8,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Denmark,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
1901733,GASPRSCFM,COUNTRY,ESP,EUR,YEAR,Europe,NA,2016,NA,NA,NA,NA,NA,NA,NA,1.64,1.64384,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Spain,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2033725,GASPRSCFM,COUNTRY,SLV,AMR,YEAR,Americas,NA,2017,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,El Salvador,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2052294,GASPRSCFM,COUNTRY,GBR,EUR,YEAR,Europe,NA,2013,NA,NA,NA,NA,NA,NA,NA,0.83,0.83333,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2091057,GASPRSCFM,COUNTRY,SVN,EUR,YEAR,Europe,NA,2009,NA,NA,NA,NA,NA,NA,NA,8.33,8.33333,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Slovenia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2110528,GASPRSCFM,COUNTRY,CYP,EUR,YEAR,Europe,NA,2011,NA,NA,NA,NA,NA,NA,NA,25.45,25.45455,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Cyprus,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2159544,GASPRSCFM,COUNTRY,DNK,EUR,YEAR,Europe,NA,2014,NA,NA,NA,NA,NA,NA,NA,5.5,5.50459,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Denmark,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2287734,GASPRSCFM,COUNTRY,SVN,EUR,YEAR,Europe,NA,2015,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Slovenia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2541952,GASPRSCFM,COUNTRY,AUT,EUR,YEAR,Europe,NA,2017,NA,NA,NA,NA,NA,NA,NA,3.8,3.8,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Austria,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2605362,GASPRSCFM,COUNTRY,LVA,EUR,YEAR,Europe,NA,2011,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Latvia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2622656,GASPRSCFM,COUNTRY,ARG,AMR,YEAR,Americas,NA,2017,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Argentina,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2660208,GASPRSCFM,COUNTRY,GRC,EUR,YEAR,Europe,NA,2018,NA,NA,NA,NA,NA,NA,NA,6,6,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Greece,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2743092,GASPRSCFM,COUNTRY,TUN,EMR,YEAR,Eastern Mediterranean,NA,2017,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Tunisia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
2800195,GASPRSCFM,COUNTRY,IRL,EUR,YEAR,Europe,NA,2017,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Ireland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3083383,GASPRSCFM,COUNTRY,CIV,AFR,YEAR,Africa,NA,2017,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Cote d'Ivoire,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3253581,GASPRSCFM,COUNTRY,BLR,EUR,YEAR,Europe,NA,2009,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Belarus,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3324577,GASPRSCFM,COUNTRY,PRT,EUR,YEAR,Europe,NA,2013,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Portugal,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3335824,GASPRSCFM,COUNTRY,SVK,EUR,YEAR,Europe,NA,2013,NA,NA,NA,NA,NA,NA,NA,4.55,4.54545,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Slovakia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3349593,GASPRSCFM,COUNTRY,ISL,EUR,YEAR,Europe,NA,2015,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Iceland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3367992,GASPRSCFM,COUNTRY,GRC,EUR,YEAR,Europe,NA,2012,NA,NA,NA,NA,NA,NA,NA,5.88,5.88235,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Greece,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3425251,GASPRSCFM,COUNTRY,ITA,EUR,YEAR,Europe,NA,2013,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Italy,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3463007,GASPRSCFM,COUNTRY,FRA,EUR,YEAR,Europe,NA,2016,NA,NA,NA,NA,NA,NA,NA,1.01,1.0101,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,France,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3556997,GASPRSCFM,COUNTRY,HUN,EUR,YEAR,Europe,NA,2012,NA,NA,NA,NA,NA,NA,NA,6.33,6.32911,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Hungary,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3558344,GASPRSCFM,COUNTRY,ECU,AMR,YEAR,Americas,NA,2018,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Ecuador,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3639852,GASPRSCFM,COUNTRY,USA,AMR,YEAR,Americas,NA,2015,NA,NA,NA,NA,NA,NA,NA,0.49,0.48572,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,United States of America,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3702222,GASPRSCFM,COUNTRY,SWE,EUR,YEAR,Europe,NA,2014,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Sweden,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3791233,GASPRSCFM,COUNTRY,HRV,EUR,YEAR,Europe,NA,2017,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Croatia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3854685,GASPRSCFM,COUNTRY,CIV,AFR,YEAR,Africa,NA,2016,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Cote d'Ivoire,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3961629,GASPRSCFM,COUNTRY,FRA,EUR,YEAR,Europe,NA,2011,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,France,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
3994576,GASPRSCFM,COUNTRY,PER,AMR,YEAR,Americas,NA,2015,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Peru,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4304376,GASPRSCFM,COUNTRY,PRT,EUR,YEAR,Europe,NA,2018,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Portugal,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4594471,GASPRSCFM,COUNTRY,LVA,EUR,YEAR,Europe,NA,2013,NA,NA,NA,NA,NA,NA,NA,2.63,2.63158,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Latvia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4638128,GASPRSCFM,COUNTRY,CAN,AMR,YEAR,Americas,NA,2013,NA,NA,NA,NA,NA,NA,NA,1.75,1.75274,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Canada,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4645575,GASPRSCFM,COUNTRY,BEL,EUR,YEAR,Europe,NA,2014,NA,NA,NA,NA,NA,NA,NA,12.14,12.14286,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Belgium,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4898213,GASPRSCFM,COUNTRY,BLR,EUR,YEAR,Europe,NA,2013,NA,NA,NA,NA,NA,NA,NA,2.5,2.5,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Belarus,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
4929675,GASPRSCFM,COUNTRY,IRL,EUR,YEAR,Europe,NA,2018,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Ireland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5017773,GASPRSCFM,COUNTRY,NLD,EUR,YEAR,Europe,NA,2014,NA,NA,NA,NA,NA,NA,NA,2.2,2.20264,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5042879,GASPRSCFM,COUNTRY,DEU,EUR,YEAR,Europe,NA,2014,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Germany,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5067924,GASPRSCFM,COUNTRY,ITA,EUR,YEAR,Europe,NA,2012,NA,NA,NA,NA,NA,NA,NA,6,6,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Italy,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5156590,GASPRSCFM,COUNTRY,CUB,AMR,YEAR,Americas,NA,2018,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Cuba,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5295783,GASPRSCFM,COUNTRY,MLT,EUR,YEAR,Europe,NA,2015,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Malta,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5364818,GASPRSCFM,COUNTRY,SVK,EUR,YEAR,Europe,NA,2018,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Slovakia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5415741,GASPRSCFM,COUNTRY,CAN,AMR,YEAR,Americas,NA,2016,NA,NA,NA,NA,NA,NA,NA,0.31,0.30851,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Canada,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5487223,GASPRSCFM,COUNTRY,DNK,EUR,YEAR,Europe,NA,2011,NA,NA,NA,NA,NA,NA,NA,2.07,2.06897,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Denmark,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5549169,GASPRSCFM,COUNTRY,MLT,EUR,YEAR,Europe,NA,2013,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Malta,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5556720,GASPRSCFM,COUNTRY,UKR,EUR,YEAR,Europe,NA,2016,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Ukraine,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5575700,GASPRSCFM,COUNTRY,FIN,EUR,YEAR,Europe,NA,2017,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Finland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5624997,GASPRSCFM,COUNTRY,DEU,EUR,YEAR,Europe,NA,2017,NA,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Germany,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5650525,GASPRSCFM,COUNTRY,CAN,AMR,YEAR,Americas,NA,2014,NA,NA,NA,NA,NA,NA,NA,1.1,1.10265,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Canada,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5753827,GASPRSCFM,COUNTRY,BEL,EUR,YEAR,Europe,NA,2018,NA,NA,NA,NA,NA,NA,NA,2.9,2.9,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Belgium,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5777459,GASPRSCFM,COUNTRY,SVK,EUR,YEAR,Europe,NA,2014,NA,NA,NA,NA,NA,NA,NA,0.92,0.91743,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Slovakia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5835329,GASPRSCFM,COUNTRY,ESP,EUR,YEAR,Europe,NA,2014,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Spain,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
5866597,GASPRSCFM,COUNTRY,LVA,EUR,YEAR,Europe,NA,2010,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Latvia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6195898,GASPRSCFM,COUNTRY,GRC,EUR,YEAR,Europe,NA,2011,NA,NA,NA,NA,NA,NA,NA,3,3,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Greece,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6537541,GASPRSCFM,COUNTRY,HUN,EUR,YEAR,Europe,NA,2018,NA,NA,NA,NA,NA,NA,NA,2.2,2.2,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Hungary,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6587196,GASPRSCFM,COUNTRY,AUT,EUR,YEAR,Europe,NA,2013,NA,NA,NA,NA,NA,NA,NA,6.42,6.42202,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Austria,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6809089,GASPRSCFM,COUNTRY,MLT,EUR,YEAR,Europe,NA,2014,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Malta,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6841208,GASPRSCFM,COUNTRY,IRL,EUR,YEAR,Europe,NA,2011,NA,NA,NA,NA,NA,NA,NA,3.13,3.125,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Ireland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
6879092,GASPRSCFM,COUNTRY,FRA,EUR,YEAR,Europe,NA,2017,NA,NA,NA,NA,NA,NA,NA,0.9,0.9,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,France,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7905901,GASPRSCFM,COUNTRY,NOR,EUR,YEAR,Europe,NA,2016,NA,NA,NA,NA,NA,NA,NA,1.8,1.8018,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Norway,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7949226,GASPRSCFM,COUNTRY,CAN,AMR,YEAR,Americas,NA,2015,NA,NA,NA,NA,NA,NA,NA,1.91,1.90931,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Canada,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
7994028,GASPRSCFM,COUNTRY,CYP,EUR,YEAR,Europe,NA,2013,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Cyprus,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8189985,GASPRSCFM,COUNTRY,SWE,EUR,YEAR,Europe,NA,2013,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Sweden,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8386415,GASPRSCFM,COUNTRY,GRC,EUR,YEAR,Europe,NA,2017,NA,NA,NA,NA,NA,NA,NA,5.6,5.6,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Greece,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8540155,GASPRSCFM,COUNTRY,BEL,EUR,YEAR,Europe,NA,2012,NA,NA,NA,NA,NA,NA,NA,0.93,0.93458,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Belgium,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8576559,GASPRSCFM,COUNTRY,ZAF,AFR,YEAR,Africa,NA,2015,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,South Africa,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
8677929,GASPRSCFM,COUNTRY,IRL,EUR,YEAR,Europe,NA,2012,NA,NA,NA,NA,NA,NA,NA,3.75,3.75,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Ireland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9013550,GASPRSCFM,COUNTRY,ISL,EUR,YEAR,Europe,NA,2014,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Iceland,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9058940,GASPRSCFM,COUNTRY,LVA,EUR,YEAR,Europe,NA,2017,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Latvia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9250033,GASPRSCFM,COUNTRY,NOR,EUR,YEAR,Europe,NA,2011,NA,NA,NA,NA,NA,NA,NA,1.3,1.2987,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Norway,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9820705,GASPRSCFM,COUNTRY,SVK,EUR,YEAR,Europe,NA,2012,NA,NA,NA,NA,NA,NA,NA,3.7,3.7037,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Slovakia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9858015,GASPRSCFM,COUNTRY,DNK,EUR,YEAR,Europe,NA,2010,NA,NA,NA,NA,NA,NA,NA,20.83,20.83333,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Denmark,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9883780,GASPRSCFM,COUNTRY,LVA,EUR,YEAR,Europe,NA,2016,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Latvia,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9895292,GASPRSCFM,COUNTRY,UKR,EUR,YEAR,Europe,NA,2015,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Ukraine,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
9977075,GASPRSCFM,COUNTRY,CIV,AFR,YEAR,Africa,NA,2014,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Cote d'Ivoire,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
10199956,GASPRSCFM,COUNTRY,DNK,EUR,YEAR,Europe,NA,2018,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Denmark,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
10213295,GASPRSCFM,COUNTRY,ITA,EUR,YEAR,Europe,NA,2016,NA,NA,NA,NA,NA,NA,NA,2,2,NA,NA,NA,2024-02-09T17:47:58.813+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Italy,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP,EN,NA
